Showing results (41-50 of 440) with videos related to
Sort By:
Pageof 44
Journal of Thrombosis and Thrombolysis|November 6, 2019
Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpointBernhard Wernly, Richard Rezar, Paul Gurbel, et al.Revista Espanola De Cardiologia (English Ed.)|May 28, 2014
Update: Acute coronary syndromes (V). Personalized antiplatelet therapyPaul A Gurbel, Rahil Rafeedheen, Udaya S TantryPolish Archives of Internal Medicine|August 17, 2019
Smoking and cardiovascular diseases: paradox greater than expected?Bogumił Ramotowski, Paul A Gurbel, Udaya Tantry, et al.American Heart Journal|September 30, 2000
Depression and ischemic heart diseaseC M O'connor, P A Gurbel, V L SerebruanyInterventional Cardiology Clinics|June 6, 2017
Does Gender have an Influence on Platelet Function and the Efficacy of Oral Antiplatelet Therapy?Udaya S Tantry, Eliano P Navarese, Paul A GurbelJRSM Cardiovascular Disease|November 1, 2013
Personalized antiplatelet therapy: state of the artPaul A Gurbel, Young-Hoon Jeong, Udaya S TantryPolskie Archiwum Medycyny Wewnetrznej|May 23, 2015
What is the best anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction?Paul A Gurbel, Eliano Pio Navarese, Udaya S TantryClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Mild myocardial stunning affects platelet aggregation and certain hemostatic factors in swineV L Serebruany, V V Yurovsky, P A GurbelPharmacological Research|June 8, 2001
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitorsV L Serebruany, P A Gurbel, C M O'ConnorReviews in Cardiovascular Medicine|May 7, 2011
The influence of CYP2C19 polymorphisms on the pharmacokinetics, pharmacodynamics, and clinical effectiveness of P2Y(12) inhibitorsMatthew J Price, Udaya S Tantry, Paul A GurbelPageof 44